Structured assessment of the risk Profile of RA patients by the rheumatology nurse

Structured assessment of the risk Profile of RA patients by the rheumatology nurse - ERIKO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010909

Enrollment

400

Registered

2016-08-02

Start date

2014-12-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis M05 M06

Interventions

Group 1: Structured assessment and classification of comorbidities and risk factors by a rheumatology nurse specialist ahead of consultation by the rheumatologist. Group 2: Standard of care

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults with Minimum Age of 18 years, capable of giving informed consent and diagnosis of rheumatoid Arthritis and stable on DMARDs or bDMARDs for at least three months.

Exclusion criteria

Exclusion criteria: Change of disease-modifying base therapy (dose, substance or interval) within the last three months.

Design outcomes

Primary

Measure	Time frame
Primary observational endpoint is the Change of the risk Profile of patients within 12 months after the first structured assessment.The risk Profile will be judged by a new composite score, consisting of the categorized results of established and validated risk assessment questionnaires.	—

Secondary

Measure	Time frame
Difference in the 12-month change of the risk profile between arm 1 and arm 2.	—

Countries

Germany

Contacts

Public ContactRolf Hecker

Abbvie Deutschland GmbH & Co. KG

rolf.hecker@abbvie.com0611-17 20 3842

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026